Alnylam Pharmaceuticals
ALNY
#579
Rank
โ‚น2.976 T
Marketcap
โ‚น23,182
Share price
1.16%
Change (1 day)
59.14%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividends for this company